Suresnes, France

François Lemare

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Institut Gustave Roussy, Orphelia Pharma. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: François Lemare. Retrieved from https://idiyas.com/inventor/françois-lemare

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: François Lemare: Innovator in Pharmaceutical Solutions

Introduction

François Lemare is a notable inventor based in Suresnes, France. He has made significant contributions to the field of pharmaceuticals, particularly with his innovative work on oral suspensions.

Latest Patents

Lemare holds a patent for an oral suspension of temozolomide. This pharmaceutical liquid suspension comprises temozolomide or a salt thereof, at least one agent controlling the solid state of temozolomide in suspension, a pharmaceutically acceptable liquid vehicle, and optionally at least one acid in a quantity that ensures the pH of the composition is below 5. Additionally, a powder blend for reconstituting the suspension is provided. He has 1 patent to his name.

Career Highlights

Throughout his career, François Lemare has worked with prominent organizations such as Orphelia Pharma and Institut Gustave Roussy. His experience in these institutions has allowed him to develop and refine his innovative ideas in the pharmaceutical sector.

Collaborations

Lemare has collaborated with talented individuals in his field, including Maxime Annereau and Jérémy Bastid. These partnerships have contributed to the advancement of his projects and innovations.

Conclusion

François Lemare's work in developing pharmaceutical solutions showcases his dedication to improving patient care through innovation. His contributions to the field are noteworthy and reflect his commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…